Administration’s adoption of benefit-cost matrix to assess the value of ‘nature’ spurs bipartisan criticism in House hearing larded with acronyms.
Administration’s adoption of benefit-cost matrix to assess the value of ‘nature’ spurs bipartisan criticism in House hearing larded with acronyms.